| Sulaiman B Hasan, MD | |
|
319 S Manning Blvd Ste 110a, Albany, NY 12208-1743 | |
| (518) 525-2525 | |
| Not Available |
| Full Name | Sulaiman B Hasan |
|---|---|
| Gender | Male |
| Speciality | Cardiac Surgery |
| Experience | 44 Years |
| Location | 319 S Manning Blvd Ste 110a, Albany, New York |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1962481689 | NPI | - | NPPES |
| 7400015000 | Medicaid | WV |
| Facility Name | Location | Facility Type |
|---|---|---|
| St Peter's Hospital | Albany, NY | Hospital |
| Samaritan Hospital | Troy, NY | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| St. Peter's Health Partners Medical Associates, P.c. | 6103061189 | 393 |
News Archive
PLC Systems Inc., a company focused on innovative medical device technologies, today reported that final results from the REMEDIAL II investigator-sponsored clinical trial of its RenalGuard System™ in Italy are scheduled to be presented at 11:57 a.m. CT on Monday, April 4, 2011, at the American College of Cardiology's 60th Annual Scientific Session & Expo in New Orleans, Louisiana. Additionally, PLC will be demonstrating RenalGuard at its booth at the conference.
Puma Biotechnology, Inc., a development stage biopharmaceutical company, announced that results from an ongoing Phase I clinical trial of its lead drug candidate PB272 (neratinib) given in combination with the anticancer drugs paclitaxel and trastuzumab in patients with metastatic HER-2 positive breast cancer were presented in a poster presentation at the American Society of Clinical Oncology (ASCO) 2012 Annual Meeting.
Scientists from USC and the IFOM Cancer Institute in Milan have found that a fasting-mimicking diet could be more effective at treating some types of cancer when combined with vitamin C.
The Methodist Hospital is the first in the U.S. to use a portable heart/lung machine to move critically ill patients easily and safely to different areas of the hospital for medical tests or from outlying hospitals to the medical center for specialized treatment. Recently approved for use in the U.S. by the FDA, the device has been used in Europe since 2008 with excellent results.
› Verified 7 days ago
| Entity Name | University Surgical Associates Llp |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1376590117 PECOS PAC ID: 7315834165 Enrollment ID: O20040304000499 |
News Archive
PLC Systems Inc., a company focused on innovative medical device technologies, today reported that final results from the REMEDIAL II investigator-sponsored clinical trial of its RenalGuard System™ in Italy are scheduled to be presented at 11:57 a.m. CT on Monday, April 4, 2011, at the American College of Cardiology's 60th Annual Scientific Session & Expo in New Orleans, Louisiana. Additionally, PLC will be demonstrating RenalGuard at its booth at the conference.
Puma Biotechnology, Inc., a development stage biopharmaceutical company, announced that results from an ongoing Phase I clinical trial of its lead drug candidate PB272 (neratinib) given in combination with the anticancer drugs paclitaxel and trastuzumab in patients with metastatic HER-2 positive breast cancer were presented in a poster presentation at the American Society of Clinical Oncology (ASCO) 2012 Annual Meeting.
Scientists from USC and the IFOM Cancer Institute in Milan have found that a fasting-mimicking diet could be more effective at treating some types of cancer when combined with vitamin C.
The Methodist Hospital is the first in the U.S. to use a portable heart/lung machine to move critically ill patients easily and safely to different areas of the hospital for medical tests or from outlying hospitals to the medical center for specialized treatment. Recently approved for use in the U.S. by the FDA, the device has been used in Europe since 2008 with excellent results.
› Verified 7 days ago
| Entity Name | Albany Cardiothoracic Surgeons |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1033159975 PECOS PAC ID: 0244205185 Enrollment ID: O20101220000722 |
News Archive
PLC Systems Inc., a company focused on innovative medical device technologies, today reported that final results from the REMEDIAL II investigator-sponsored clinical trial of its RenalGuard System™ in Italy are scheduled to be presented at 11:57 a.m. CT on Monday, April 4, 2011, at the American College of Cardiology's 60th Annual Scientific Session & Expo in New Orleans, Louisiana. Additionally, PLC will be demonstrating RenalGuard at its booth at the conference.
Puma Biotechnology, Inc., a development stage biopharmaceutical company, announced that results from an ongoing Phase I clinical trial of its lead drug candidate PB272 (neratinib) given in combination with the anticancer drugs paclitaxel and trastuzumab in patients with metastatic HER-2 positive breast cancer were presented in a poster presentation at the American Society of Clinical Oncology (ASCO) 2012 Annual Meeting.
Scientists from USC and the IFOM Cancer Institute in Milan have found that a fasting-mimicking diet could be more effective at treating some types of cancer when combined with vitamin C.
The Methodist Hospital is the first in the U.S. to use a portable heart/lung machine to move critically ill patients easily and safely to different areas of the hospital for medical tests or from outlying hospitals to the medical center for specialized treatment. Recently approved for use in the U.S. by the FDA, the device has been used in Europe since 2008 with excellent results.
› Verified 7 days ago
| Entity Name | St. Peter's Health Partners Medical Associates, P.c. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1750626834 PECOS PAC ID: 6103061189 Enrollment ID: O20130321000567 |
News Archive
PLC Systems Inc., a company focused on innovative medical device technologies, today reported that final results from the REMEDIAL II investigator-sponsored clinical trial of its RenalGuard System™ in Italy are scheduled to be presented at 11:57 a.m. CT on Monday, April 4, 2011, at the American College of Cardiology's 60th Annual Scientific Session & Expo in New Orleans, Louisiana. Additionally, PLC will be demonstrating RenalGuard at its booth at the conference.
Puma Biotechnology, Inc., a development stage biopharmaceutical company, announced that results from an ongoing Phase I clinical trial of its lead drug candidate PB272 (neratinib) given in combination with the anticancer drugs paclitaxel and trastuzumab in patients with metastatic HER-2 positive breast cancer were presented in a poster presentation at the American Society of Clinical Oncology (ASCO) 2012 Annual Meeting.
Scientists from USC and the IFOM Cancer Institute in Milan have found that a fasting-mimicking diet could be more effective at treating some types of cancer when combined with vitamin C.
The Methodist Hospital is the first in the U.S. to use a portable heart/lung machine to move critically ill patients easily and safely to different areas of the hospital for medical tests or from outlying hospitals to the medical center for specialized treatment. Recently approved for use in the U.S. by the FDA, the device has been used in Europe since 2008 with excellent results.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Sulaiman B Hasan, MD Po Box 14890, Albany, NY 12212-4890 Ph: (518) 525-5634 | Sulaiman B Hasan, MD 319 S Manning Blvd Ste 110a, Albany, NY 12208-1743 Ph: (518) 525-2525 |
News Archive
PLC Systems Inc., a company focused on innovative medical device technologies, today reported that final results from the REMEDIAL II investigator-sponsored clinical trial of its RenalGuard System™ in Italy are scheduled to be presented at 11:57 a.m. CT on Monday, April 4, 2011, at the American College of Cardiology's 60th Annual Scientific Session & Expo in New Orleans, Louisiana. Additionally, PLC will be demonstrating RenalGuard at its booth at the conference.
Puma Biotechnology, Inc., a development stage biopharmaceutical company, announced that results from an ongoing Phase I clinical trial of its lead drug candidate PB272 (neratinib) given in combination with the anticancer drugs paclitaxel and trastuzumab in patients with metastatic HER-2 positive breast cancer were presented in a poster presentation at the American Society of Clinical Oncology (ASCO) 2012 Annual Meeting.
Scientists from USC and the IFOM Cancer Institute in Milan have found that a fasting-mimicking diet could be more effective at treating some types of cancer when combined with vitamin C.
The Methodist Hospital is the first in the U.S. to use a portable heart/lung machine to move critically ill patients easily and safely to different areas of the hospital for medical tests or from outlying hospitals to the medical center for specialized treatment. Recently approved for use in the U.S. by the FDA, the device has been used in Europe since 2008 with excellent results.
› Verified 7 days ago
Lewis W Britton, MD Thoracic Surgery (Cardiothoracic Vascular Surgery) Medicare: Medicare Enrolled Practice Location: 7 Southwoods Blvd, Capital Cardiology Associates, Pc Div Of Cardio Surgery, Albany, NY 12211 Phone: 518-292-6000 Fax: 518-641-6766 | |
Stephanie Elizabeth Helmer, M.D. Thoracic Surgery (Cardiothoracic Vascular Surgery) Medicare: Accepting Medicare Assignments Practice Location: 319 S Manning Blvd Ste 110a, Albany, NY 12208 Phone: 518-525-2525 Fax: 518-525-2522 | |
Adanna Akujuo, M.D. Thoracic Surgery (Cardiothoracic Vascular Surgery) Medicare: Accepting Medicare Assignments Practice Location: 47 New Scotland Ave, Mc 192, Albany, NY 12208 Phone: 518-262-9777 Fax: 518-262-9778 | |
Brian Nicholas Arnold, M.D. Thoracic Surgery (Cardiothoracic Vascular Surgery) Medicare: Medicare Enrolled Practice Location: 50 New Scotland Ave # Mc192, Albany, NY 12208 Phone: 518-262-5864 Fax: 518-262-9933 | |
Stuart J Miller, MD Thoracic Surgery (Cardiothoracic Vascular Surgery) Medicare: Medicare Enrolled Practice Location: 50 New Scotland Ave # Mc-192, Division Of Cardio-thoracic Surgery, Albany, NY 12208 Phone: 518-262-9777 Fax: 518-262-9778 | |
Ralph Clement Darling Iii, MD Thoracic Surgery (Cardiothoracic Vascular Surgery) Medicare: Accepting Medicare Assignments Practice Location: 391 Myrtle Ave, Suite 5, The Vascular Group, Pllc, Albany, NY 12208 Phone: 518-262-5640 Fax: 518-262-9413 | |
Dennis J Rassias, MD Thoracic Surgery (Cardiothoracic Vascular Surgery) Medicare: Accepting Medicare Assignments Practice Location: 317 S Manning Blvd, Suite 280, Albany, NY 12208 Phone: 518-454-0846 Fax: 518-454-0849 |